Piramal Pharmaceutical Development Services Profile
Key Indicators
- Authorised Capital ₹ 200.00 Cr
- Paid Up Capital ₹ 150.05 Cr
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2014
About Piramal Pharmaceutical Development Services
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24230MH2008PTC182850
-
Company No.
182850
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 May 2008
-
Date of AGM
24 Jul 2014
-
Date of Balance Sheet
31 Mar 2014
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Piramal Pharmaceutical Development Services?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chanda Thadani
|
Company Secretary | 01-Sep-2014 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Vijay Shah
|
Director | 18-Jun-2012 | Current |
|
Rajesh Laddha
|
Director | 30-Jun-2008 | Current |
|
Vivek Valsaraj
|
Additional Director | 18-Sep-2014 | Current |
Financial Performance of Piramal Pharmaceutical Development Services.
Enhance accessibility to Piramal Pharmaceutical Development Services's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Piramal Pharmaceutical Development Services?
Unlock access to Piramal Pharmaceutical Development Services's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Steel Infra Solutions Private LimitedRajesh Laddha is a mutual person
-
Bennett Coleman And Company LimitedChanda Thadani is a mutual person
-
Piramal Enterprises LimitedVijay Shah is a mutual person
-
Piramal Pharma Limited
Vivek Valsaraj is a mutual person
-
Abbvie Therapeutics India Private LimitedVivek Valsaraj is a mutual person
-
Pegasus Assets Reconstruction Private LimitedRajesh Laddha is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Piramal Pharmaceutical Development Services?
Unlock and access historical data on people associated with Piramal Pharmaceutical Development Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Piramal Pharmaceutical Development Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Piramal Pharmaceutical Development Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
